XML 92 R78.htm IDEA: XBRL DOCUMENT v3.19.2
Business Combination (Details) - USD ($)
Feb. 08, 2019
Dec. 31, 2018
Allocation of the purchase price:    
Cash and cash equivalents   $ 636,666
Accounts receivable, net   43,204
Property and equipment, net   58,150
Security deposits   147,848
Total assets acquired   896,308
Accrued expenses and other current liabilities   (83,026)
Total liabilities assumed   (85,906)
Total net assets acquired   $ 43,531,445
BioLite and BioKey [Member]    
Purchase consideration:    
Common Stock [1] $ 44,341,847  
Allocation of the purchase price:    
Cash and cash equivalents 531,147  
Accounts receivable, net 188,550  
Property and equipment, net 56,075  
Operating lease right-of-use assets 485,684  
Security deposits 10,440  
Total assets acquired 1,271,896  
Accounts payable (56,204)  
Accrued expenses and other current liabilities (251,335)  
Operating lease liability (267,256)  
Tenant security deposit (2,880)  
Total liabilities assumed (577,675)  
Total net assets acquired 694,221  
Goodwill as a result of the Merger $ 43,647,626  
[1] 29,561,231 shares of ABVC common stock issued to BioKey in connection with the Merger. Those shares were valued at $1.50 per share, based on the bid-and-ask share price of ABVC Common Stock on the final day of trading, February 8, 2019.